I must admit I see the Winery as a non core asset so I am delighted it so 30% gone.Lets focus on the upside which is exploration in Indonesia.But we need to see a board restructure before the Shareprice will move.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%